LUMSDAINE ALFRED (Chief Financial Officer) received a stock award from ARDENT HEALTH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/2/2026ACC: 0001628280-26-023205
Officer· Chief Financial Officer
Since Mar 2026
+46.95K
Net shares
Net buyer
$59.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
53.85K acquired · 6.89K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.51K
Price / share
$8.56
Trade value
$21.49K
% of position
0.9%
3/31/2026
272.23K→269.72K
Common Stock
Direct
Shares
−4.38K
Price / share
$8.67
Trade value
$37.98K
% of position
1.6%
4/1/2026
269.72K→265.34K
Common Stock
Direct
Shares
+53.85K
Price / share
—
Trade value
—
% of position
20.3%
4/1/2026
265.34K→319.18K
Total
Net shares
+46.95K
Net value
-$59.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2026 | F · Tax Withholding | −2.51K | $8.56 | $21.49K | 0.9% | 272.23K | 269.72K |
| Common Stock Direct | 4/1/2026 | F · Tax Withholding | −4.38K | $8.67 | $37.98K | 1.6% | 269.72K | 265.34K |
| Common Stock Direct | 4/1/2026 | A · Award | +53.85K | — | — | 20.3% | 265.34K | 319.18K |
| Total | +46.95K | -$59.47K | ||||||
Derivative Transactions0
No derivative transactions reported